A study of 96,000 hospitalized coronavirus patients on six continents found that those who received an antimalarial drug promoted by President Trump as a “game changer” in the fight against the virus had a significantly higher risk of death compared with those who did not.
CDC Director Robert Redfield on Thursday denied reports that the White House rejected his agency's draft guidelines for reopening the country and wouldn't commit to resuming regular briefings as states continue lifting coronavirus lockdowns.
One of the first COVID patients in Massachusetts to receive the experimental "convalescent plasma" treatment did beat the odds -- but he got many treatments simultaneously, so it's not clear what made the difference.
The Centers for Disease Control and Prevention has acknowledged that it is mixing the results of two different kinds of tests in the agency's tally of testing for the coronavirus, raising concerns among some scientists that it could be creating an inaccurate picture of the state of the pandemic in the United States.
A newly released analysis of coronavirus' spread in the U.S. suggests a haunting hypothetical: that if social distancing and stay-at-home orders had been implemented only a week earlier, more than 30,000 lives might have been saved. But that alternate scenario relies upon computer-based modeling that has its limitations.
COLUMBUS, Ohio - An executive at an Ohio hospital accused Battelle, a science company lauded by Gov. Mike DeWine for its newfound ability to decontaminate N95 respirators, of price gouging. Lisa Geiger, CFO of Alliance Community Hospital in Stark County, filed a price gouging complaint with Attorney General Dave Yost's office on April 2.